Skip to main content

Weather Alert

Hurricane activity is severely impacting Quest locations across the Southeast. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational.

Hide
Quest Diagnostics

Moving in the Fast Lane: Test Design and Validation to Produce Up-to-Date Hereditary Breast and Gynecologic Cancer Tests

SABCS 2020:  San Antonio Breast Cancer Symposium 
Virtual [in-person conference canceled], Dec 8-12, 2020

Moving in the fast lane: test design and validation to produce up-to-date hereditary breast and gynecologic cancer tests

Authors: Angeloni TG, Bhattacharya A, Cheng LL, Chong HK, Conlan KM, Elzinga CD, Gerasimova A, Grover D, Grupe A, Hua M, Hodko D, Kazmierkiewicz K, Nakles RE, Nery CR, Owen R, Root DM, Rowland CM, Smolgovsky A, Weltmer EC, Zhang K, Lacbawan FL

Specialties: oncology, women's health, OB/GYN

Download key summary

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.